PDF(Pubmed)
Abstract：
UNASSIGNED: The advantage of transcervical radiofrequency ablation (TRFA) is that it is minimally invasive, incision-free, and treats a wide spectrum of fibroids, including those that are not accessible by surgical hysteroscopy (FIGO 3, 4, 5, 6, and 2-5). However, there are no publications describing a combined procedure of operative hysteroscopy and TRFA yet, so it was still unknown whether a combined procedure is associated with additional risks.
UNASSIGNED: To report the combined technique of transcervical intrauterine radiofrequency ablation of fibroids and surgical hysteroscopy.
UNASSIGNED: Our study was designed to show the results of our case series with 21 patients. The retrospective study included only patients who were treated with the combined procedure of surgical hysteroscopy with fibroid and/or endometrial resection and fibroid ablation using the Sonata System.
UNASSIGNED: The combined procedure was performed without any complications in all cases. Two days after surgery, no increased morbidity was observed compared to only conventional surgical hysteroscopy and/or therapy with the TRFA. All patients were satisfied with the procedure. No late complications were observed within the first 6 months postoperatively. Seventeen patients with bleeding symptoms were asked about their subjective assessment of improvement. Fifteen patients reported significant improvement in symptoms and 1 patient reported only minimal improvement. Only 1 patient, who underwent TRFA and endometrial resection, did not report any improvement. No increase in symptoms was observed.
UNASSIGNED: Although TRFA is an approved method, it is not yet widely used worldwide. The combined procedure has been rarely used. The aim of our work is to show through our case series that transcervical radiofrequency ablation can be combined with surgical hysteroscopy for fibroid and/or endometrial resection without any additional risk.
UNASSIGNED: To report the combined technique of transcervical intrauterine radiofrequency ablation of fibroids and surgical hysteroscopy.
UNASSIGNED: Our study was designed to show the results of our case series with 21 patients. The retrospective study included only patients who were treated with the combined procedure of surgical hysteroscopy with fibroid and/or endometrial resection and fibroid ablation using the Sonata System.
UNASSIGNED: The combined procedure was performed without any complications in all cases. Two days after surgery, no increased morbidity was observed compared to only conventional surgical hysteroscopy and/or therapy with the TRFA. All patients were satisfied with the procedure. No late complications were observed within the first 6 months postoperatively. Seventeen patients with bleeding symptoms were asked about their subjective assessment of improvement. Fifteen patients reported significant improvement in symptoms and 1 patient reported only minimal improvement. Only 1 patient, who underwent TRFA and endometrial resection, did not report any improvement. No increase in symptoms was observed.
UNASSIGNED: Although TRFA is an approved method, it is not yet widely used worldwide. The combined procedure has been rarely used. The aim of our work is to show through our case series that transcervical radiofrequency ablation can be combined with surgical hysteroscopy for fibroid and/or endometrial resection without any additional risk.
摘要：
■经颈射频消融（TRFA）的优点是微创，无切口,治疗广泛的肌瘤，包括那些无法通过宫腔镜手术（图3、4、5、6和2-5）。然而,目前还没有出版物描述宫腔镜手术和TRFA的组合程序，因此,联合手术是否与其他风险相关尚不清楚.
■报告宫颈子宫肌瘤射频消融术与宫腔镜手术的联合技术。
■我们的研究旨在显示我们对21例患者的病例系列结果。回顾性研究仅包括使用Sonata系统进行宫腔镜手术与肌瘤和/或子宫内膜切除术以及肌瘤消融术联合治疗的患者。
■在所有情况下都进行了联合手术，没有任何并发症。手术两天后,与常规宫腔镜手术和/或TRFA治疗相比,未观察到发病率增加.所有患者对手术均满意。术后前6个月无晚期并发症发生。17例有出血症状的患者被问及他们对改善的主观评价。15例患者报告症状显着改善，1例患者仅报告最小改善。只有1个病人,他们接受了TRFA和子宫内膜切除术，没有报告任何改进。没有观察到症状的增加。
■尽管TRFA是一种认可的方法，它尚未在世界范围内广泛使用。该组合程序很少使用。我们的工作的目的是通过我们的病例系列表明，经宫颈射频消融可以与手术宫腔镜联合进行肌瘤和/或子宫内膜切除术，而没有任何额外的风险。
■报告宫颈子宫肌瘤射频消融术与宫腔镜手术的联合技术。
■我们的研究旨在显示我们对21例患者的病例系列结果。回顾性研究仅包括使用Sonata系统进行宫腔镜手术与肌瘤和/或子宫内膜切除术以及肌瘤消融术联合治疗的患者。
■在所有情况下都进行了联合手术，没有任何并发症。手术两天后,与常规宫腔镜手术和/或TRFA治疗相比,未观察到发病率增加.所有患者对手术均满意。术后前6个月无晚期并发症发生。17例有出血症状的患者被问及他们对改善的主观评价。15例患者报告症状显着改善，1例患者仅报告最小改善。只有1个病人,他们接受了TRFA和子宫内膜切除术，没有报告任何改进。没有观察到症状的增加。
■尽管TRFA是一种认可的方法，它尚未在世界范围内广泛使用。该组合程序很少使用。我们的工作的目的是通过我们的病例系列表明，经宫颈射频消融可以与手术宫腔镜联合进行肌瘤和/或子宫内膜切除术，而没有任何额外的风险。
